Inhibition of Human T-Cell Proliferation by mTOR Antagonists Requires Non-Coding RNA Growth-Arrest- Specific Transcript 5 (GAS5)

[1]  Xiaoying Zhang,et al.  Sarcophine-diol, a Chemopreventive Agent of Skin Cancer, Inhibits Cell Growth and Induces Apoptosis through Extrinsic Pathway in Human Epidermoid Carcinoma A431 Cells. , 2009, Translational oncology.

[2]  B. Jiang,et al.  Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. , 2008, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[3]  M. Mourtada-Maarabouni,et al.  Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5) , 2008, Journal of Cell Science.

[4]  X. Bai,et al.  Rheb Activates mTOR by Antagonizing Its Endogenous Inhibitor, FKBP38 , 2007, Science.

[5]  A. Soulard,et al.  SnapShot: mTOR Signaling , 2007, Cell.

[6]  M. Gharagozloo,et al.  Effects of silymarin on the spontaneous proliferation and cell cycle of human peripheral blood leukemia T cells , 2007, Journal of Cancer Research and Clinical Oncology.

[7]  M. Hall,et al.  TOR Signaling in Growth and Metabolism , 2006, Cell.

[8]  J. Blenis,et al.  mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4E , 2004, Molecular and Cellular Biology.

[9]  L. Shaw,et al.  Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses , 2003, Transplantation.

[10]  Johannes Gerdes,et al.  The Ki‐67 protein: From the known and the unknown , 2000, Journal of cellular physiology.

[11]  R. Schwartz,et al.  Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation. , 1999, Journal of immunology.

[12]  Christine C. Hudson,et al.  Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. , 1997, Science.

[13]  J. Steitz,et al.  A mammalian gene with introns instead of exons generating stable RNA products , 1996, Nature.

[14]  James M. Roberts,et al.  lnterleukin-2-mediated elimination of the p27Kipl cyclin-dependent kinase inhibitor prevented by rapamycin , 1994, Nature.

[15]  N. Sonenberg,et al.  Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E , 1993, Molecular and cellular biology.

[16]  E. Coccia,et al.  Regulation and expression of a growth arrest-specific gene (gas5) during growth, differentiation, and development. , 1992, Molecular and cellular biology.

[17]  B. Vogelstein,et al.  Participation of p53 protein in the cellular response to DNA damage. , 1991, Cancer research.

[18]  N. Sigal,et al.  The immunosuppressive macrolides FK-506 and rapamycin act as reciprocal antagonists in murine T cells. , 1990, Journal of immunology.

[19]  E. Thompson,et al.  Characterization of a glucocorticoid-sensitive human lymphoid cell line. , 1977, Cancer research.

[20]  G. Moore,et al.  Rosette-forming human lymphoid cell lines. I. Establishment and evidence for origin of thymus-derived lymphocytes. , 1972, Journal of the National Cancer Institute.

[21]  R. Abraham,et al.  Immunopharmacology of rapamycin. , 1996, Annual review of immunology.